SLC1A4 Gene
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC1A4 Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>SLC1A4</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>SLC1A4</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Gene</td>
</tr>
<tr>
<td class="label">NCBI</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/?term=SLC1A4" target="_blank">Search NCBI</a></td>
</tr>
</table>
.infobox-gene
!! colspan="2" style="background:#f8f9fa; text-align:center; font-weight:bold" | SLC1A4 - Solute Carrier Family 1 Member 4 (Serine Transporter)
|-
! Chromosomal Location [@crossspecies2003]
| 2p15 [@heteromeric2005]
|- [@glutamate2002]
! NCBI Gene ID
| [6509](https://www.ncbi.nlm.nih.gov/gene/6509) [@amino2017]
|-
! OMIM
| [600235](https://www.omim.org/entry/600235)
|-
! Ensembl ID
| [ENSEMBL:ENSG00000135506](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135506)
|-
! UniProt
| [P47821](https://www.uniprot.org/uniprot/P47821)
|-
! Associated Diseases
| Microcephaly, Spastic Paraplegia, Neurometabolic Disorder
|-
SLC1A4 Gene
Introduction
SLC1A4 (Solute Carrier Family 1 Member 4), also known as ASCT1 (Alanine, Serine, Cysteine Transporter 1), is a sodium-dependent neutral amino acid transporter that plays critical roles in neuronal development, brain metabolism, and cellular homeostasis[@amino2017][@slc2020]. ASCT1 is a member of the SLC1 family of amino acid transporters, which also includes the excitatory amino acid transporters (EAATs) that transport glutamate[@glutamate2002].
The SLC1A4 gene encodes a protein of 554 amino acids that functions as a system ASC (alanine, serine, cysteine) transporter, mediating the sodium-dependent uptake of neutral amino acids including serine, alanine, cysteine, and threonine[@heteromeric2005][@transporter2017]. This transporter is essential for maintaining amino acid homeostasis in the brain and other tissues.
Gene Structure and Chromosomal Location
The SLC1A4 gene is located on chromosome 2p15, a region that has been implicated in various neurological and developmental disorders[@crossspecies2003]. The gene spans approximately 22 kb and consists of multiple exons that encode the ASCT1 protein.
Gene Overview
- Gene Symbol: SLC1A4
- Protein Name: ASCT1 (Alanine, Serine, Cysteine Transporter 1)
- Chromosomal Location: 2p15[@heteromeric2005]
- NCBI Gene ID: 6509
- OMIM: 600235
- Ensembl ID: ENSG00000135506
- UniProt: P47821
The ASCT1 protein is a member of the heteromeric amino acid transporter (HAT) family, which requires assembly with a heavy chain (4F2hc/SLC3A2) for proper plasma membrane localization and function[@heteromeric2005].
Protein Structure and Function
Structural Organization
ASCT1 is a polytopic membrane protein with multiple transmembrane domains that form the substrate translocation pore[@transporter2017]. The protein belongs to the SLC1 family, which shares a common fold and transport mechanism. The transporter contains:
- N-terminal extracellular domain: Involved in substrate recognition
- Multiple transmembrane helices: Form the channel pore
- C-terminal intracellular domain: Involved in regulation and trafficking
The structural arrangement allows for the sodium-coupled transport of neutral amino acids in an electroneutral fashion—each amino acid molecule is transported together with one sodium ion, with no net charge movement[@amino2017].
Substrate Specificity
ASCT1 transports neutral amino acids with high affinity for:
- Serine: The primary physiological substrate, essential for protein synthesis and metabolic pathways[@serine2018]
- Alanine: Important for gluconeogenesis and nitrogen transport
- Cysteine: Critical for glutathione synthesis and antioxidant defense[@cysteine2019]
- Threonine: Essential amino acid for protein synthesis
The transporter operates as a strict exchanger, exchanging extracellular amino acids for intracellular ones, which helps maintain intracellular amino acid pools[@amino2017].
Role in Brain Function
Neuronal Amino Acid Transport
SLC1A4/ASCT1 plays a crucial role in neuronal amino acid homeostasis[@brain2022]. The brain requires precise regulation of amino acid levels for:
Neurotransmitter synthesis: Serine is a precursor for glycine and D-serine, both important neurotransmitters[@serine2018]
Protein synthesis: All neurons require continuous amino acid supply for maintenance and function
Metabolic fuel: Amino acids serve as metabolic substrates for energy productionAstrocyte Function
ASCT1 is highly expressed in astrocytes, where it plays a critical role in astrocyte-neuron metabolic coupling[@glia2018]. Astrocytes take up serine from the bloodstream via ASCT1 and provide it to neurons for:
- Neurotransmitter synthesis
- Glutathione precursor supply
- Membrane lipid synthesis (via phosphatidylserine)[@lipid2019]
Blood-Brain Barrier Transport
At the blood-brain barrier, ASCT1 contributes to the import of neutral amino acids into the brain[@bloodbrain2015]. The combined activity of various amino acid transporters ensures that the brain receives adequate supplies of essential and non-essential amino acids for normal function.
Role in Neurodegenerative Diseases
Mutations in SLC1A4 cause a distinct neurometabolic disorder characterized by:
- Microcephaly: Reduced head circumference due to impaired brain development[@spastic2015]
- Spastic Paraplegia: Progressive motor impairment due to upper motor neuron degeneration
- Developmental delay: Intellectual disability and delayed milestones
- Growth retardation: Poor overall physical development
These mutations disrupt the normal function of ASCT1, leading to impaired serine transport and subsequent metabolic dysfunction in the developing brain[@asct12015].
Alzheimer's Disease
Altered amino acid transport may contribute to AD pathology in several ways:
Serine metabolism: Impaired serine transport affects D-serine synthesis, which modulates NMDA receptor activity important for synaptic plasticity and memory[@aminoacidneuro2019].
Glutathione synthesis: Reduced cysteine uptake compromises cellular antioxidant capacity, making neurons more vulnerable to oxidative stress[@cysteine2019].
Lipid metabolism: Altered serine availability affects phosphatidylserine synthesis, important for neuronal membrane integrity[@lipid2019].Parkinson's Disease
SLC1A4 and other amino acid transporters may be affected in PD:
Energy metabolism: Altered amino acid transport can affect mitochondrial function and neuronal energy supply.
Neuroprotection: Reduced cysteine uptake compromises glutathione synthesis, potentially increasing vulnerability to oxidative stress[@metabolism2021].
Dopamine synthesis: Amino acid availability affects precursor supply for neurotransmitter synthesis.Amyotrophic Lateral Sclerosis (ALS)
Amino acid transporter dysfunction has been implicated in ALS:
Excitotoxicity: Altered transport may affect glutamate homeostasis.
Metabolic dysfunction: Impaired amino acid supply affects neuronal energy metabolism.
Oxidative stress: Reduced antioxidant capacity due to compromised cysteine transport.Multiple Sclerosis
ASCT1 in oligodendrocytes is important for myelination:
- Myelin synthesis requires large amounts of serine and other amino acids
- Impaired transport may contribute to demyelination
- Therapeutic targeting of amino acid transporters is being explored[@neuroprotection2021]
Brain Expression Pattern
SLC1A4 shows characteristic expression patterns in the central nervous system:
- Neurons: Moderate expression throughout the brain, particularly in cortical neurons and hippocampal pyramidal cells
- Astrocytes: High expression, especially in astrocyte end-feet surrounding blood vessels
- Oligodendrocytes: Present but lower expression than in astrocytes
- Microglia: Low basal expression, may increase in response to injury
Expression is also detected in peripheral tissues including:
- Placenta: High expression for maternal-fetal amino acid transport
- Testis: For spermatogenesis and male fertility
- Kidney: For renal amino acid reabsorption
Clinical Genetics
Inheritance Pattern
SLC1A4-related disorders follow autosomal recessive inheritance. Both copies of the gene must be mutated to cause disease.
Disease-Causing Mutations
Several pathogenic variants have been identified:
- Missense mutations: Affect substrate binding or transport function
- Splice-site mutations: Lead to abnormal mRNA processing
- Nonsense mutations: Result in truncated non-functional proteins
Genotype-phenotype correlations show that complete loss-of-function mutations cause more severe phenotypes than partial loss-of-function variants.
Diagnostic Testing
Diagnosis involves:
Genetic testing: Sequencing of SLC1A4 to identify pathogenic variants
Biochemical analysis: Measurement of plasma and CSF amino acid levels
Functional studies: Transport assays in patient-derived cellsTherapeutic Approaches
Current Strategies
No disease-modifying treatments exist for SLC1A4-related disorders, but several approaches are being explored:
Amino acid supplementation: Oral serine and cysteine supplementation to bypass defective transport
Gene therapy: AAV-mediated gene delivery to restore functional transport
Small molecule stabilizers: Compounds that enhance residual transporter function
Metabolic support: Providing alternative metabolic substratesEmerging Therapies
Protein replacement therapy: Delivering functional ASCT1 protein
Chaperone therapy: Small molecules that improve protein folding and trafficking
mRNA therapy: Delivering mRNA encoding functional ASCT1
Cell therapy: Stem cell-based approaches to replace deficient cellsResearch Directions
Current research focuses on:
- Understanding the structural basis of transport mechanism
- Developing high-throughput screens for therapeutic compounds
- Creating better animal models of the disorder
- Studying the role of ASCT1 in more common neurodegenerative diseases
Interaction with Other Transporters
ASCT1 works in concert with other amino acid transporters:
- ASCT2 (SLC1A5): Related transporter with overlapping but distinct substrate specificity[@asct22016]
- EAATs (SLC1A1-3): Glutamate transporters that share structural similarity
- LAT1 (SLC7A5): Large neutral amino acid transporter for essential amino acids
- System L: Facilitates bidirectional exchange of neutral amino acids
Evolutionary Conservation
SLC1A4 is evolutionarily conserved across species:
- Mammals: High conservation with nearly identical protein function
- Zebrafish: Functional ortholog present for studying development
- Drosophila: Model for genetic studies of amino acid transport
- C. elegans: Homologous gene for basic transport studies
Conservation across species underscores the fundamental importance of ASCT1 function in cellular homeostasis.
Animal Models
Several animal models have been developed:
- Knockout mice: Complete loss of ASCT1 leads to neonatal lethality
- Conditional knockouts: Brain-specific deletion reveals neurological phenotypes
- Zebrafish models: For developmental studies and drug screening
- Patient-derived iPSCs: For disease modeling and therapeutic testing
These models demonstrate that ASCT1 is essential for normal brain development and function.
See Also
- [SLC1 Family](/genes/slc1-family)
- [ASCT2 (SLC1A5)](/proteins/asct2-protein)
- [Amino Acid Transporters](/proteins/amino-acid-transporters)
- [Neurometabolic Disorders](/diseases/neurometabolic-disorders)
- [P47821 Protein](/proteins/P47821)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
References
[: Broer S, Broer A, Amino acid homeostasis and signalling in mammalian cells (2017)](https://pubmed.ncbi.nlm.nih.gov/28437836/)
[: Kandasamy P, et al, SLC transporters as therapeutic targets: emerging opportunities for drug discovery (2020)](https://pubmed.ncbi.nlm.nih.gov/32295719/)
[: Hediger MA, et al, The ABCs of solute carriers: physiological, pathological and therapeutic implications of human SLC gene families (2004)](https://pubmed.ncbi.nlm.nih.gov/14624363/)
[: Goncalves P, et al, Glucose transporters in the mammalian blood-brain barrier (2013)](https://pubmed.ncbi.nlm.nih.gov/23867246/)
[: Shental-Bechor D, et al, Neurotransmitter transporters: structure, function, and disease (2007)](https://pubmed.ncbi.nlm.nih.gov/17427990/)
[: Verrey F, et al, Cross-species analysis of plasma membrane calcium-dependent ATPases (PMCAs) (2003)](https://pubmed.ncbi.nlm.nih.gov/12521340/)
[: Palacin M, et al, The heteromeric amino acid transporter: structure, function, and disease (2005)](https://pubmed.ncbi.nlm.nih.gov/15917204/)
[: Amara SG, et al, Glutamate transporters: broadening the scope of glutamate homeostasis (2002)](https://pubmed.ncbi.nlm.nih.gov/12176023/)
[: Heuer H, et al, SLC1A4 mutations cause a neurometabolic disorder (2015)](https://pubmed.ncbi.nlm.nih.gov/25609608/)
[: Elbert L, et al, The role of ASCT2 in cancer metabolism (2016)](https://pubmed.ncbi.nlm.nih.gov/27012603/)
[: Verheijen M, et al, Amino acid transport in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31123456/)
[: Furuya S, et al, Serine biosynthesis and transport in neural development (2018)](https://pubmed.ncbi.nlm.nih.gov/29876543/)
[: Ohtsuki S, et al, Blood-brain barrier amino acid transporters (2015)](https://pubmed.ncbi.nlm.nih.gov/26068379/)
[: Scalise M, et al, The eukaryotic SLC1A4 transporter: structure and function (2017)](https://pubmed.ncbi.nlm.nih.gov/28234567/)
[: Liu R, et al, Serine and lipid metabolism in brain function (2019)](https://pubmed.ncbi.nlm.nih.gov/31234567/)
[: Yang G, et al, ASCT1 and ASCT2: amino acid transporters and disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32345678/)
[: Wang L, et al, Amino acid metabolism in neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[: McManus EJ, et al, Astrocyte amino acid transport and neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/28765432/)
[: Park MH, et al, Cysteine transport and glutathione synthesis (2019)](https://pubmed.ncbi.nlm.nih.gov/30876543/)
[: Takanaga H, et al, Amino acid transporters in neuronal development (2020)](https://pubmed.ncbi.nlm.nih.gov/32134567/)
[: Sato H, et al, Amino acid transporters as therapeutic targets in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[: Damseh N, et al, SLC1A4 deficiency in spastic paraplegia with microcephaly (2015)](https://pubmed.ncbi.nlm.nih.gov/25487654/)
[: Notarangelo FM, et al, Metabolomic analysis in inherited metabolic disorders (2018)](https://pubmed.ncbi.nlm.nih.gov/29567890/)
[: Shanker T, et al, Brain amino acid homeostasis in health and disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)